Microbix Biosystems Inc.
MBXBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -22.6% | -34.8% | -11.9% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -46.9% | 40.8% | 59.5% | 62.1% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -35.1% | -28% | 13.1% | 25.2% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -39.5% | -47.3% | 0.4% | 14.2% |
| EPS Diluted | -0.008 | -0.012 | 0 | 0.006 |
| % Growth | 36.7% | -12,100% | -98.4% | – |
| Operating Cash Flow | $0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |